venBio Global Strategic Fund III, L.P. 13D and 13G filings for Pharvaris N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 6:41 pm Purchase | 2023-12-06 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III, L.P. | 4,382,504 8.400% | 117,832 (+2.76%) | Filing |
| 2023-06-21 4:33 pm Purchase | 2023-06-16 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III, L.P. | 4,264,672 10.400% | 1,963,221 (+85.30%) | Filing |
| 2022-09-26 4:24 pm Sale | 2021-02-09 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III, L.P. | 2,301,451 6.900% | -1,859 (-0.08%) | Filing |
| 2021-02-19 4:49 pm Purchase | 2021-02-09 | 13D | Pharvaris N.V. PHVS | venBio Global Strategic Fund III, L.P. | 2,303,310 7.000% | 2,303,310 (New Position) | Filing |